|
⚲
|
| Keyboard |
| Oberman Allan
✚
|
|
|---|---|
| CIK # | 0001656585 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001656585] | |
| 4 | [0001656585] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sagent Pharmaceuticals Inc | |
| Oberman Allan |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2016-08-29 | Disposed to issuer | 9,459 | $21.75 | 205,733 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2016-08-29 | Disposed to issuer | 92,527 | $21.75 | 2,012,462 |
|
Sagent Pharmaceuticals Inc SGNT
Stock Option to Buy · derivative
|
2016-08-29 | Disposed to issuer | 108,696 | $7.14 | 776,089 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2016-08-03 | Tax withheld | 4,271 | $21.74 | 92,852 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2016-02-22 | Grant | 51,335 | $0.00 | |
|
Sagent Pharmaceuticals Inc SGNT
Stock Option to Buy · derivative
|
2016-02-22 | Grant | 108,696 | $0.00 | |
|
Sagent Pharmaceuticals Inc SGNT
Stock Option to Buy · derivative
|
2015-08-03 | Grant | 110,020 | $0.00 | |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-08-03 | Grant | 54,922 | $0.00 |